SHIM
ANAB icon

Stone House Investment Management’s AnaptysBio ANAB Stock Holding History

Stone House Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$666 Sell
12
-1
-8% -$54 ﹤0.01% 767
2025
Q4 		$630 Buy
13
+8
+160% +$312 ﹤0.01% 696
2025
Q3 		$153 Buy
+5
New +$115 ﹤0.01% 709

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Stone House Investment Management's ANAB Position: Q1 2026 in Review

Stone House Investment Management reduced its AnaptysBio (ANAB) stake by 7.7% in Q1 2026, selling an estimated $54 and leaving 12 shares worth $666. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Stone House Investment Management first reported a position in ANAB in Q3 2025 and has held it in 3 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Stone House Investment Management held 12 shares of AnaptysBio worth $666 as of Q1 2026.
  • Stone House Investment Management sold 1 AnaptysBio share in Q1 2026, an estimated $54.
  • AnaptysBio made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #767 holding.
  • Stone House Investment Management first reported a position in AnaptysBio in Q3 2025 and has held it in 3 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.